Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations

Journal of Chromatography A

Volumn 1430, Issue , 2016, Pages 97-112

  Jeanneret, Fabienne ^a,b   Tonoli, David ^a,b   Rossier, Michel F ^b,c   Saugy, Martial ^d   Boccard, Julien ^a   Rudaz, Serge ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Swiss Centre for Applied Human Toxicology   (Switzerland)

^c Institut Central des Hopitaux Valaisans   (Switzerland)

^d University Center of Legal Medicine   (Switzerland)

Author keywords

Chromatography; Human disease; Mass spectrometry; Metabolomics; Review; Steroid analysis; Steroidomics

Indexed keywords

CHROMATOGRAPHY; GAS CHROMATOGRAPHY; IMMUNOLOGY; LIPIDS; MASS SPECTROMETRY; PHYSIOLOGY; REVIEWS;

ANALYTICAL STRATEGY; BIOLOGICAL FUNCTIONS; HUMAN DISEASE; METABOLOMICS; SELECTED REACTION MONITORING; STEROID ANALYSIS; STEROIDOMICS; TECHNICAL REQUIREMENT;

LIQUID CHROMATOGRAPHY;

ANDROGEN; BIOLOGICAL MARKER; ENDOCRINE DISRUPTOR; ESTROGEN; GESTAGEN; GLUCOCORTICOID; STEROID;

BIOMICS; BLOOD ANALYSIS; BURN; CACHEXIA; CARDIOTOXICITY; CROSS REACTION; DATA PROCESSING; DEPRESSION; DIABETES MELLITUS; DOPING; ENVIRONMENTAL EXPOSURE; GYNECOMASTIA; HUMAN; HYPERGLYCEMIA; IMMUNOASSAY; INBORN ERROR OF STEROID METABOLISM; INJURY; LIQUID CHROMATOGRAPHY; LIVER TOXICITY; MALE INFERTILITY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SALIVA ANALYSIS; SEMEN ANALYSIS; STEROID ANALYSIS; STEROID METABOLISM; STEROIDOGENESIS; STEROIDOMICS; URINALYSIS; CHEMISTRY; METABOLISM; METABOLOME; PROCEDURES; SUBSTANCE ABUSE;

CROSS REACTIONS; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; METABOLOME; METABOLOMICS; STEROIDS; SUBSTANCE ABUSE DETECTION;

EID: 84937161068     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.07.008     Document Type: Review

References (183)

1. [1] Fanelli, F., Belluomo, I., Di Lallo, V.D., Cuomo, G., De Iasio, R., Baccini, M., Casadio, E., Casetta, B., Vicennati, V., Gambineri, A., Grossi, G., Pasquali, R., Pagotto, U., Serum steroid profiling by isotopic dilution–liquid chromatography–mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 76 (2011), 244–253.
2. [2] Holst, J.P., Soldin, O.P., Guo, T.D., Soldin, S.J., Steroid hormones: relevance and measurement in the clinical laboratory. Clin. Lab. Med. 24 (2004), 105–118.
3. [3] Minutti, C.Z., Lacey, J.M., Magera, M.J., Hahn, S.H., McCann, M., Schulze, A., Cheillan, D., Dorche, C., Chace, D.H., Lymp, J.F., Zimmerman, D., Rinaldo, P., Matern, D., Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J. Clin. Endocr. Metab. 89 (2004), 3687–3693.
4. [4] Acerini, C.L., Hughes, I.A., Endocrine disrupting chemicals: a new and emerging public health problem?. Arch. Dis. Child. 91 (2006), 633–638.
5. [5] De Coster, S., van Larebeke, N., Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J. Environ. Public Health, 2012, 1–52 id713696.
6. [6] Schug, T.T., Janesick, A., Blumberg, B., Heindel, J.J., Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 127 (2011), 204–215.
7. [7] Leung, K.S., Fong, B.M., LC–MS/MS in the routine clinical laboratory: has its time come?. Anal. Bioanal. Chem. 406 (2014), 2289–2301.
8. [8] Wu, A.H.B., French, D., Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin. Chim. Acta 420 (2013), 4–10.
9. [9] Rauh, M., Steroid measurement with LC–MS/MS. Application examples in pediatrics. J. Steroid Biochem. 121 (2010), 520–527.
10. [10] Soldin, S.J., Soldin, O.P., Steroid hormone analysis by tandem mass spectrometry. Clin. Chem. 55 (2009), 1061–1066.
11. [11] Vogeser, M., Kirchhoff, F., Progress in automation of LC–MS in laboratory medicine. Clin. Biochem. 44 (2011), 4–13.
12. [12] Wu, A.H., Gerona, R., Armenian, P., French, D., Petrie, M., Lynch, K.L., Role of liquid chromatography–high-resolution mass spectrometry (LC–HR/MS) in clinical toxicology. Clin. Toxicol. 50 (2012), 733–742.
13. [13] Ramanathan, R., Jemal, M., Ramagiri, S., Xia, Y.Q., Humpreys, W.G., Olah, T., Korfmacher, W.A., It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J. Mass Spectrom. 46 (2011), 595–601.
14. [14] Henry, H., Sobhi, H.R., Scheibner, O., Bromirski, M., Nimkar, S.B., Rochat, B., Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs. Rapid Commun. Mass Spectrom. 26 (2012), 499–509.
15. [15] Plumb, R., Castro-Perez, J., Granger, J., Beattie, I., Joncour, K., Wright, A., Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18 (2004), 2331–2337.
16. [16] Hayes, R., Ahmed, A., Edge, T., Zhang, H., Core–shell particles: preparation, fundamentals and applications in high performance liquid chromatography. J. Chromatogr. A 1357 (2014), 36–52.
17. [17] Boccard, J., Rutledge, D.N., A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion. Anal. Chim. Acta 769 (2013), 30–39.
18. [18] Boccard, J., Rudaz, S., Harnessing the complexity of metabolomic data with chemometrics. J. Chemometrics 28 (2014), 1–9.
19. [19] Eichner, J., Rosenbaum, L., Wrzodek, C., Haring, H.U., Zell, A., Lehmann, R., Integrated enrichment analysis and pathway-centered visualization of metabolomics, proteomics, transcriptomics, and genomics data by using the InCroMAP software. J. Chromatogr. B 966 (2014), 77–82.
20. [20] Kuo, T.C., Tian, T.F., Tseng, Y.J., 3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data. BMC Syst. Biol., 7, 2013, 64.
21. [21] Sjovall, J., Fifty years with bile acids and steroids in health and disease. Lipids 39 (2004), 703–722.
22. [22] Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A., HMDB 3.0 – the human metabolome database in 2013. Nucleic Acids Res. 41 (2013), D801–D807.
23. [23] Sanderson, J.T., The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol. Sci. 94 (2006), 3–21.
24. [24] Arukwe, A., Steroidogenic acute regulatory (StAR) protein and cholesterol side-chain cleavage (P450scc)-regulated steroidogenesis as an organ-specific molecular and cellular target for endocrine disrupting chemicals in fish. Cell Biol. Toxicol. 24 (2008), 527–540.
25. [25] Miller, W.L., Auchus, R.J., The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32 (2011), 81–151.
26. [26] Payne, A.H., Hales, D.B., Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25 (2004), 947–970.
27. [27] Strott, C.A., Sulfonation and molecular action. Endocr. Rev. 23 (2002), 703–732.
28. [28] Ha, Y.W., Moon, J.Y., Jung, H.J., Chung, B.C., Choi, M.H., Evaluation of plasma enzyme activities using gas chromatography–mass spectrometry based steroid signatures. J. Chromatogr. B 877 (2009), 4125–4132.
29. [29] Krone, N., Hughes, B.A., Lavery, G.G., Stewart, P.M., Arlt, W., Shackleton, C.H.L., Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121 (2010), 496–504.
30. [30] Fahy, E., Subramaniam, S., Murphy, R.C., Nishijima, M., Raetz, C.R.H., Shimizu, T., Spener, F., van Meer, G., Wakelam, M.J.O., Dennis, E.A., Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 50 (2009), S9–S14.
31. [31] Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., Tanabe, M., Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42 (2014), D199–D205.
32. [32] Shackleton, C.H.L., Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis. Lipids 47 (2012), 1–12.
33. [33] Ferraldeschi, R., Sharifi, N., Auchus, R.J., Attard, G., Molecular pathways: inhibiting steroid biosynthesis in prostate cancer. Clin. Cancer Res. 19 (2013), 3353–3359.
34. [34] MacVicar, G.R., Hussain, M.H., Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer. Curr. Opin. Oncol. 25 (2013), 252–260.
35. [35] Obiorah, I.E., Fan, P., Sengupta, S., Jordan, V.C., Selective estrogen-induced apoptosis in breast cancer. Steroids 90 (2014), 60–70.
36. [36] Jordan, V.C., A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention. Cancer Res. 69 (2009), 1243–1254.
37. [37] Carlsen, E., Giwercman, A., Keiding, N., Skakkebaek, N.E., Evidence for decreasing quality of semen during past 50 years. Brit. Med. J. 305 (1992), 609–613.
38. [38] Skakkebaek, N.E., Rajpert-De Meyts, E., Main, K.M., Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16 (2001), 972–978.
39. [39] Wild, C.P., Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14 (2005), 1847–1850.
40. [40] Harding, A.K., Daston, G.P., Boyd, G.R., Lucier, G.W., Safe, S.H., Stewart, J., Tillitt, D.E., Van der Kraak, G., Endocrine disrupting chemicals research program of the US Environmental Protection Agency: summary of a peer-review report. Environ. Health Persp. 114 (2006), 1276–1282.
41. [41] Anway, M.D., Cupp, A.S., Uzumcu, M., Skinner, M.K., Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 (2005), 1466–1469.
42. [42] Anway, M.D., Skinner, M.K., Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147 (2006), S43–S49.
43. [43] Louis, G.M.B., Cooney, M.A., Peterson, C.M., The ovarian dysgenesis syndrome. J. Dev. Orig. Health Dis. 2 (2011), 25–35.
44. [44] Fowler, P.A., Bellingham, M., Sinclair, K.D., Evans, N.P., Pocar, P., Fischer, B., Schaedlich, K., Schmidt, J.S., Amezaga, M.R., Bhattacharya, S., Rhind, S.M., O'Shaughnessy, P.J., Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol. Cell. Endocrinol. 355 (2012), 231–239.
45. [45] Elobeid, M.A., Allison, D.B., Putative environmental-endocrine disruptors and obesity: a review. Curr. Opin. Endocrinol. Diabetes Obes. 15 (2008), 403–408.
46. [46] Hampl, R., Kubatova, J., Starka, L., Steroids and endocrine disruptors – history, recent state of art and open questions. J. Steroid Biochem. Mol. Biol., 2014, 10.1016/j.jsbmb.2014.1004.1013.
47. [47] Kortenkamp, A., Scholze, M., Ermler, S., Mind the gap: can we explain declining male reproductive health with known antiandrogens?. Reproduction 147 (2014), 515–527.
48. [48] Martin, O.V., Shialis, T., Lester, J.N., Scrimshaw, M.D., Boobis, A.R., Voulvoulis, N., Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ. Health Persp. 116 (2008), 149–157.
49. [49] Nohynek, G.J., Borgert, C.J., Dietrich, D., Rozman, K.K., Endocrine disruption: fact or urban legend?. Toxicol. Lett. 223 (2013), 295–305.
50. [50] Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., Zoeller, R.T., Gore, A.C., Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 30 (2009), 293–342.
51. [51] Kwon, S., Hermayer, K.L., Glucocorticoid-induced hyperglycemia. Am. J. Med. Sci. 345 (2013), 274–277.
52. [52] Shahidi, N.T., A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin. Ther. 23 (2001), 1355–1390.
53. [53] Basaria, S., Wahlstrom, J.T., Dobs, A.S., Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J. Clin. Endocrinol. Metab. 86 (2001), 5108–5117.
54. [54] Kicman, A.T., Pharmacology of anabolic steroids. Brit. J. Pharmacol. 154 (2008), 502–521.
55. [55] Brynhildsen, J., Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther. Adv. Drug Saf. 5 (2014), 201–213.
56. [56] Reeves, G.K., Beral, V., Green, J., Gathani, T., Bull, D., Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 7 (2006), 910–918.
57. [57] Fournier, A., Mesrine, S., Boutron-Ruault, M.C., Clavel-Chapelon, F., Estrogen–progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?. J. Clin. Oncol. 27 (2009), 5138–5143.
58. [58] Ceglarek, U., Werner, M., Kortz, L., Korner, A., Kiess, W., Thiery, J., Kratzsch, J., Preclinical challenges in steroid analysis of human samples. J. Steroid Biochem. Mol. Biol. 121 (2010), 505–512.
59. [59] New, M.I., Inborn errors of adrenal steroidogenesis. Mol. Cell. Endocrinol. 211 (2003), 75–83.
60. [60] Makin, H.L.J., Gower, D.B., Steroid Analysis. 2nd ed., 2010, Springer, Netherlands, Dordrecht.
61. [61] Jerjes, W.K., Cleare, A.J., Peters, T.J., Taylor, N.F., Circadian rhythm of urinary steroid metabolites. Ann. Clin. Biochem. 43 (2006), 287–294.
62. [62] Badoud, F., Guillarme, D., Boccard, J., Grata, E., Saugy, M., Rudaz, S., Veuthey, J.L., Analytical aspects in doping control: challenges and perspectives. Forensic Sci. Int. 213 (2011), 49–61.
63. [63] W.A.-D.A. (W.A.D.A.), Endogenous Anabolic Androgenic Steroids, Measurement and Reporting, TD2014EAAS. 2014.
64. [64] Badoud, F., Grata, E., Boccard, J., Guillarme, D., Veuthey, J.L., Rudaz, S., Saugy, M., Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry. Anal. Bioanal. Chem. 400 (2011), 503–516.
65. [65] Kushnir, M.M., Rockwood, A.L., Roberts, W.L., Yue, B.F., Bergquist, J., Meikle, A.W., Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin. Biochem. 44 (2011), 77–88.
66. [66] Wagner, M., Tonoli, D., Varesio, E., Hopfgartner, G., The use of mass spectrometry to analyze dried blood spots. Mass Spectrom. Rev., 2014, 10.1002/mas.21441.
67. [67] Groschl, M., Kohler, H., Topf, H.G., Rupprecht, T., Rauh, M., Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. J. Pharm. Biomed. Anal. 47 (2008), 478–486.
68. [68] de Lacerda, L., Kowarski, A., Migeon, C.J., Integrated concentration of plasma cortisol in normal subjects. J. Clin. Endocrinol. Metab. 36 (1973), 227–238.
69. [69] Manetti, L., Rossi, G., Grasso, L., Raffaelli, V., Scattina, I., Del Sarto, S., Cosottini, M., Iannelli, A., Gasperi, M., Bogazzi, F., Martino, E., Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol. Eur. J. Endocrinol. 168 (2013), 315–321.
70. [70] Keevil, B.G., MacDonald, P., Macdowall, W., Lee, D.M., Wu, F.C., Team, N., Salivary testosterone measurement by liquid chromatography tandem mass spectrometry in adult males and females. Ann. Clin. Biochem. 51 (2014), 368–378.
71. [71] Aardal, E., Holm, A.C., Cortisol in saliva – reference ranges and relation to cortisol in serum. Eur. J. Clin. Chem. Clin. 33 (1995), 927–932.
72. [72] Loughlin, K.R., Changes in male fertility in the last two decades. Urol. Clin. North Am. 39 (2012), 33–36.
73. [73] Hampl, R., Pohanka, M., Hill, M., Starka, L., The content of four immunomodulatory steroids and major androgens in human semen. J. Steroid. Biochem. Mol. Biol. 84 (2003), 307–316.
74. [74] Pohanka, M., Hampl, R., Sterzl, I., Starka, L., Steroid hormones in human semen with particular respect to dehydroepiandrosterone and its immunomodulatory metabolites. Endocr. Regul. 36 (2002), 79–86.
75. [75] Wang, T., Rainey, W.E., Human adrenocortical carcinoma cell lines. Mol. Cell. Endocrinol. 351 (2012), 58–65.
76. [76] Hecker, M., Hollert, H., Cooper, R., Vinggaard, A.M., Akahori, Y., Murphy, M., Nellemann, C., Higley, E., Newsted, J., Wu, R., Lam, P., Laskey, J., Buckalew, A., Grund, S., Nakai, M., Timm, G., Giesy, J., The OECD validation program of the H295R steroidogenesis assay for the identification of in vitro inhibitors and inducers of testosterone and estradiol production. Phase 2: Inter-laboratory pre-validation studies. Environ. Sci. Pollut. Res. 14 (2007), 23–30.
77. [77] Hecker, M., Hollert, H., Cooper, R., Vinggaard, A.M., Akahori, Y., Murphy, M., Nellemann, C., Higley, E., Newsted, J., Laskey, J., Buckalew, A., Grund, S., Maletz, S., Giesy, J., Timm, G., The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study. Environ. Sci. Pollut. Res. 18 (2011), 503–515.
78. [78] Nielsen, F.K., Hansen, C.H., Fey, J.A., Hansen, M., Jacobsen, N.W., Halling-Sorensen, B., Bjorklund, E., Styrishave, B., H295R cells as a model for steroidogenic disruption: a broader perspective using simultaneous chemical analysis of 7 key steroid hormones. Toxicol. In Vitro 26 (2012), 343–350.
79. [79] Kang, S., Park, S., Kim, M.J., Oh, S.M., Chung, K.H., Lee, S., A sensitive and selective LC–MS/MS analysis coupled with an online sample enrichment technique for H295R steroidogenesis assay and its application in the investigation of the effect of sildenafil on steroidogenesis. Anal. Bioanal. Chem. 405 (2013), 9489–9496.
80. [80] Rijk, J.C.W., Peijnenburg, A.A.C.M., Blokland, M.H., Lommen, A., Hoogenboom, R.L.A.P., Bovee, T.F.H., Screening for modulatory effects on steroidogenesis using the human H295R adrenocortical cell line: a metabolomics approach. Chem. Res. Toxicol. 25 (2012), 1720–1731.
81. [81] Tonoli, D., Furstenberger, C., Boccard, J., Hochstrasser, D., Jeanneret, F., Odermatt, A., Rudaz, S., Steroidomic footprinting based on ultra-high performance liquid chromatography coupled with qualitative and quantitative high-resolution mass spectrometry for the evaluation of endocrine disrupting chemicals in H295R cells. Chem. Res. Toxicol. 28 (2015), 955–966.
82. [82] Roulet, V., Denis, H., Staub, C., Le Tortorec, A., Delaleu, B., Satie, A.P., Patard, J.J., Jegou, B., Dejucq-Rainsford, N., Human testis in organotypic culture: application for basic or clinical research. Hum. Reprod. 21 (2006), 1564–1575.
83. [83] Forgacs, A.L., Ding, Q., Jaremba, R.G., Huhtaniemi, I.T., Rahman, N.A., Zacharewski, T.R., BLTK1 murine leydig cells: a novel steroidogenic model for evaluating the effects of reproductive and developmental toxicants. Toxicol. Sci. 127 (2012), 391–402.
84. [84] Desdoits-Lethimonier, C., Albert, O., Le Bizec, B., Perdu, E., Zalko, D., Courant, F., Lesne, L., Guille, F., Dejucq-Rainsford, N., Jegou, B., Human testis steroidogenesis is inhibited by phthalates. Hum. Reprod. 27 (2012), 1451–1459.
85. [85] Albert, O., Desdoits-Lethimonier, C., Lesne, L., Legrand, A., Guille, F., Bensalah, K., Dejucq-Rainsford, N., Jegou, B., Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Hum. Reprod. 28 (2013), 1890–1898.
86. [86] Havelock, J.C., Rainey, W.E., Carr, B.R., Ovarian granulosa cell lines. Mol. Cell. Endocrinol. 228 (2004), 67–78.
87. [87] Ophir, L., Yung, Y., Maman, E., Rubinstein, N., Yerushalmi, G.M., Haas, J., Barzilay, E., Hourvitz, A., Establishment and validation of a model for non-luteinized human mural granulosa cell culture. Mol. Cell. Endocrinol. 384 (2014), 165–174.
88. [88] Choi, D.H., Lee, W.S., Won, M., Park, M., Park, H.O., Kim, E., Lee, K.A., Bae, J., The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis. J. Proteome Res. 9 (2010), 4329–4336.
89. [89] Chatterjee, R., Helal, M., Mobberley, M., Ryder, T., Bajoria, R., Impaired steroidogenesis and apoptosis of granulosa-luteal cells in primary culture induced by cis-platinum. Am. J. Obstet. Gynecol. 210:252 (2014), e1–e7.
90. [90] Mellon, S.H., Griffin, L.D., Neurosteroids: biochemistry and clinical significance. Trends Endocrin. Met. 13 (2002), 35–43.
91. [91] Pelletier, G., Steroidogenic enzymes in the brain: morphological aspects. Prog. Brain Res. 181 (2010), 193–207.
92. [92] Daviaud, N., Garbayo, E., Schiller, P.C., Perez-Pinzon, M., Montero-Menei, C.N., Organotypic cultures as tools for optimizing central nervous system cell therapies. Exp. Neurol. 248 (2013), 429–440.
93. [93] Melcangi, R.C., Panzica, G., Garcia-Segura, L.M., Neuroactive steroids: focus on human brain. Neuroscience 191 (2011), 1–5.
94. [94] Hogberg, H.T., Bressler, J., Christian, K.M., Harris, G., Makri, G., O'Driscoll, C., Pamies, D., Smirnova, L., Wen, Z., Hartung, T., Toward a 3D model of human brain development for studying gene/environment interactions. Stem Cell Res. Ther., 4, 2013 S4:1–7.
95. [95] Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P., Knoblich, J.A., Cerebral organoids model human brain development and microcephaly. Nature 501 (2013), 373–379.
96. [96] Slominski, A., Zbytek, B., Nikolakis, G., Manna, P.R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C.C., Tuckey, R.C., Steroidogenesis in the skin: implications for local immune functions. J. Steroid Biochem. Mol. Biol. 137 (2013), 107–123.
97. [97] Tiganescu, A., Hupe, M., Uchida, Y., Mauro, T., Elias, P.M., Holleran, W.M., Increased glucocorticoid activation during mouse skin wound healing. J. Endocrinol. 221 (2014), 51–61.
98. [98] Hannen, R.F., Michael, A.E., Jaulim, A., Bhogal, R., Burrin, J.M., Philpott, M.P., Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem. Bioph. Res. Commun. 404 (2011), 62–67.
99. [99] Petrova, A., Celli, A., Jacquet, L., Dafou, D., Crumrine, D., Hupe, M., Arno, M., Hobbs, C., Cvoro, A., Karagiannis, P., Devito, L., Sun, R., Adame, L.C., Vaughan, R., McGrath, J.A., Mauro, T.M., Ilic, D., 3D in vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells. Stem Cell Rep. 2 (2014), 675–689.
100. [100] Sweeley, C.C., Horning, E.C., Microanalytical separation of steroids by gas chromatography. Nature 187 (1960), 144–145.
101. [101] Haisenleder, D.J., Schoenfelder, A.H., Marcinko, E.S., Geddis, L.M., Marshall, J.C., Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays. Endocrinology 152 (2011), 4443–4447.
102. [102] Buttler, R.M., Kruit, A., Blankenstein, M.A., Heijboer, A.C., Measurement of dehydroepiandrosterone sulphate (DHEAS): a comparison of Isotope-Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC–MS/MS) and seven currently available immunoassays. Clin. Chim. Acta 424 (2013), 22–26.
103. [103] Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M., Raff, H., Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J. Clin. Endocr. Metab. 92 (2007), 405–413.
104. [104] Handelsman, D.J., Wartofsky, L., Requirement for mass spectrometry sex steroid assays in the journal of clinical endocrinology and metabolism. J. Clin. Endocr. Metab. 98 (2013), 3971–3973.
105. [105] Wartofsky, L., Handelsman, D.J., Standardization of hormonal assays for the 21st century. J. Clin. Endocr. Metab. 95 (2010), 5141–5143.
106. [106] Eneroth, P., Hellstroem, K., Ryhage, R., Identification and quantification of neutral fecal steroids by gas–liquid chromatography and mass spectrometry: studies of human excretion during two dietary regimens. J. Lipid Res. 5 (1964), 245–262.
107. [107] Moon, J.Y., Jung, H.J., Moon, M.H., Chung, B.C., Choi, M.H., Heat-map visualization of gas chromatography–mass spectrometry based quantitative signatures on steroid metabolism. J. Am. Soc. Mass Spectr. 20 (2009), 1626–1637.
108. [108] Shackleton, C., Clinical steroid mass spectrometry: a 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosis. J. Steroid Biochem. Mol. Biol. 121 (2010), 481–490.
109. [109] Liberato, D.J., Yergey, A.L., Esteban, N., Gomezsanchez, C.E., Shackleton, C.H.L., Thermospray Hplc/Ms – a new mass-spectrometric technique for the profiling of steroids. J. Steroid Biochem. Mol. Biol. 27 (1987), 61–70.
110. [110] Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F., Whitehouse, C.M., Electrospray ionization for mass-spectrometry of large biomolecules. Science 246 (1989), 64–71.
111. [111] Tamae, D., Byrns, M., Marck, B., Mostaghel, E.A., Nelson, P.S., Lange, P., Lin, D., Taplin, M.E., Balk, S., Ellis, W., True, L., Vessella, R., Montgomery, B., Blair, I.A., Penning, T.M., Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum. J. Steroid Biochem. Mol. Biol. 138 (2013), 281–289.
112. [112] Yamashita, K., Okuyama, M., Nakagawa, R., Honma, S., Satoh, F., Morimoto, R., Ito, S., Takahashi, M., Numazawa, M., Development of sensitive derivatization method for aldosterone in liquid chromatography–electrospray ionization tandem mass spectrometry of corticosteroids. J. Chromatogr. A 1200 (2008), 114–121.
113. [113] Rigdova, K., Wang, Y., Ward, M., Griffiths, W.J., A new derivative for oxosteroid analysis by mass spectrometry. Biochem. Biophys. Res. Commun. 446 (2014), 762–767.
114. [114] Guo, T., Taylor, R.L., Singh, R.J., Soldin, S.J., Simultaneous determination of 12 steroids by isotope dilution liquid chromatography–photospray ionization tandem mass spectrometry. Clin. Chim. Acta 372 (2006), 76–82.
115. [115] Guo, T.D., Chan, M., Soldin, S.J., Steroid profiles using liquid chromatography–tandem mass spectrometry with atmospheric pressure photoionization source. Arch. Pathol. Lab. Med. 128 (2004), 469–475.
116. [116] Guo, T.D., Gu, J.H., Soldin, O.P., Singh, R.J., Soldin, S.J., Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography–tandem mass spectrometry without derivatization. Clin. Biochem. 41 (2008), 736–741.
117. [117] Kao, P.C., Machacek, D.A., Magera, M.J., Lacey, J.M., Rinaldo, P., Diagnosis of adrenal cortical dysfunction by liquid chromatography–tandem mass spectrometry. Ann. Clin. Lab. Sci. 31 (2001), 199–204.
118. [118] Taylor, A., Shackleton, C., Taylor, S., Jensen, U.G., Ojala, M., Arlt, W., Concurrent analysis of 10 serum steroids by mass spectrometry: investigation of the viability of the Perkin-Elmer CHS™ MSMS steroids kit on a waters xevo mass spectrometer with acquity UPLC system. Endocr. Abstr., 25, 2011, P300.
119. [119] Koal, T., Schmiederer, D., Pham-Tuan, H., Rohring, C., Rauh, M., Standardized LC–MS/MS based steroid hormone profile-analysis. J. Steroid Biochem. Mol. Biol. 129 (2012), 129–138.
120. [120] Rossi, C., Calton, L., Hammond, G., Brown, H.A., Wallace, A.M., Sacchetta, P., Morris, M., Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography–tandem mass spectrometry. Clin. Chim. Acta 411 (2010), 222–228.
121. [121] Lih, F.B., Titus, M.A., Mohler, J.L., Tomer, K.B., Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer. Anal. Chem. 82 (2010), 6000–6007.
122. [122] Ceglarek, U., Kortz, L., Leichtle, A., Fiedler, G.M., Kratzsch, J., Thiery, J., Rapid quantification of steroid patterns in human serum by on-line solid phase extraction combined with liquid chromatography–triple quadrupole linear ion trap mass spectrometry. Clin. Chim. Acta 401 (2009), 114–118.
123. [123] Dhillon, K., Ho, T., Rich, P., Xu, D.D., Lorey, F., She, J.W., Bhandal, A., An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns. Clin. Chim. Acta 412 (2011), 2076–2084.
124. [124] Galuska, C.E., Hartmann, M.F., Sanchez-Guijo, A., Bakhaus, K., Geyer, J., Schuler, G., Zimmer, K.P., Wudy, S.A., Profiling intact steroid sulfates and unconjugated steroids in biological fluids by liquid chromatography–tandem mass spectrometry (LC–MS-MS). Analyst 138 (2013), 3792–3801.
125. [125] Lapthorn, C., Pullen, F., Chowdhry, B.Z., Ion mobility spectrometry–mass spectrometry (IMS–MS) of small molecules: separating and assigning structures to ions. Mass Spectrom. Rev. 32 (2013), 43–71.
126. [126] Ray, J.A., Kushnir, M.M., Yost, R.A., Rockwood, A.L., Wayne Meikle, A., Performance enhancement in the measurement of 5 endogenous steroids by LC–MS/MS combined with differential ion mobility spectrometry. Clin. Chim. Acta 438 (2015), 330–336.
127. [127] Kaur-Atwal, G., Reynolds, J.C., Mussell, C., Champarnaud, E., Knapman, T.W., Ashcroft, A.E., O'Connor, G., Christie, S.D.R., Creaser, C.S., Determination of testosterone and epitestosterone glucuronides in urine by ultra performance liquid chromatography–ion mobility-mass spectrometry. Analyst 136 (2011), 3911–3916.
128. [128] Ahonen, L., Fasciotti, M., af Gennas, G.B., Kotiaho, T., Daroda, R.J., Eberlin, M., Kostiainen, R., Separation of steroid isomers by ion mobility mass spectrometry. J. Chromatogr. A 1310 (2013), 133–137.
129. [129] Jin, W., Jarvis, M., Star-Weinstock, M., Altemus, M., A sensitive and selective LC-differential mobility-mass spectrometric analysis of allopregnanolone and pregnanolone in human plasma. Anal. Bioanal. Chem. 405 (2013), 9497–9508.
130. [130] Stanczyk, F.Z., Lee, J.S., Santen, R.J., Standardization of steroid hormone assays: why, how, and when?. Cancer Epidem. Biomarkers Prev. 16 (2007), 1713–1719.
131. [131] Vesper, H.W., Bhasin, S., Wang, C., Tai, S.S., Dodge, L.A., Singh, R.J., Nelson, J., Ohorodnik, S., Clarke, N.J., Salameh, W.A., Parker, C.R. Jr., Razdan, R., Monsell, E.A., Myers, G.L., Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 74 (2009), 498–503.
132. [132] Vesper, H.W., Botelho, J.C., Shacklady, C., Smith, A., Myers, G.L., CDC project on standardizing steroid hormone measurements. Steroids 73 (2008), 1286–1292.
133. [133] French, D., Development and validation of a serum total testosterone liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay calibrated to NIST SRM 971. Clin. Chim. Acta 415 (2013), 109–117.
134. [134] Kushnir, M.M., Rockwood, A.L., Bergquist, J., Liquid chromatography–tandem mass spectrometry applications in endocrinology. Mass Spectrom. Rev. 29 (2010), 480–502.
135. [135] Rauh, M., Steroid measurement with LC–MS/MS in pediatric endocrinology. Mol. Cell. Endocrinol. 301 (2009), 272–281.
136. [136] Abdel-Khalik, J., Bjorklund, E., Hansen, M., Simultaneous determination of endogenous steroid hormones in human and animal plasma and serum by liquid or gas chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 928 (2013), 58–77.
137. [137] Goodacre, R., Vaidyanathan, S., Dunn, W.B., Harrigan, G.G., Kell, D.B., Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22 (2004), 245–252.
138. [138] Dettmer, K., Aronov, P.A., Hammock, B.D., Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26 (2007), 51–78.
139. [139] Theodoridis, G.A., Gika, H.G., Want, E.J., Wilson, I.D., Liquid chromatography–mass spectrometry based global metabolite profiling: a review. Anal. Chim. Acta 711 (2012), 7–16.
140. [140] Castillo, S., Gopalacharyulu, P., Yetukuri, L., Oresic, M., Algorithms and tools for the preprocessing of LC–MS metabolomics data. Chemometr. Intell. Lab. 108 (2011), 23–32.
141. [141] Boccard, J., Veuthey, J.L., Rudaz, S., Knowledge discovery in metabolomics: an overview of MS data handling. J. Sep. Sci. 33 (2010), 290–304.
142. [142] Katajamaa, M., Oresic, M., Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A 1158 (2007), 318–328.
143. [143] Zhao, X., Xu, F., Qi, B., Hao, S., Li, Y., Li, Y., Zou, L., Lu, C., Xu, G., Hou, L., Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography–mass spectrometry. J. Proteome Res. 13 (2014), 1101–1111.
144. [144] Hill, M., Parizek, A., Kancheva, R., Duskova, M., Velikova, M., Kriz, L., Klimkova, M., Paskova, A., Zizka, Z., Matucha, P., Meloun, M., Starka, L., Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J. Steroid Biochem. Mol. Biol. 121 (2010), 594–610.
145. [145] Hill, M., Pašková, A., Kančeva, R., Velíková, M., Kubátová, J., Kancheva, L., Adamcová, K., Mikešová, M., Žižka, Z., Koucký, M., Šarapatková, H., Kačer, V., Matucha, P., Meloun, M., Pařízek, A., Steroid profiling in pregnancy: a focus on the human fetus. J. Steroid Biochem. Mol. Biol. 139 (2014), 201–222.
146. [146] Jantti, S.E., Hartonen, M., Hilvo, M., Nygren, H., Hyotylainen, T., Ketola, R.A., Kostiainen, R., Steroid and steroid glucuronide profiles in urine during pregnancy determined by liquid chromatography–electrospray ionization-tandem mass spectrometry. Anal. Chim. Acta 802 (2013), 56–66.
147. [147] Arlt, W., Biehl, M., Taylor, A.E., Hahner, S., Libe, R., Hughes, B.A., Schneider, P., Smith, D.J., Stiekema, H., Krone, N., Porfiri, E., Opocher, G., Bertherat, J., Mantero, F., Allolio, B., Terzolo, M., Nightingale, P., Shackleton, C.H.L., Bertagna, X., Fassnacht, M., Stewart, P.M., Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J. Clin. Endocr. Metab. 96 (2011), 3775–3784.
148. [148] Konieczna, L., Baczek, T., Belka, M., Fel, A., Markuszewski, M., Struck, W., Markuszewski, M., Kaliszan, R., Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry. J. Pharm. Biomed. Anal. 73 (2013), 108–115.
149. [149] Dai, W.D., Huang, Q., Yin, P.Y., Li, J., Zhou, J., Kong, H.W., Zhao, C.X., Lu, X., Xu, G.W., Comprehensive and highly sensitive urinary steroid hormone profiling method based on stable isotope-labeling liquid chromatography mass spectrometry. Anal. Chem. 84 (2012), 10245–10251.
150. [150] Dai, W.D., Yin, P.Y., Chen, P., Kong, H.W., Luo, P., Xu, Z.L., Lu, X., Xu, G.W., Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis. Anal. Bioanal. Chem. 406 (2014), 4325–4335.
151. [151] Gaikwad, N.W., Ultra performance liquid chromatography–tandem mass spectrometry method for profiling of steroid metabolome in human tissue. Anal. Chem. 85 (2013), 4951–4960.
152. [152] Griffiths, W., Why steroidomics in brain?. Eur. J. Lipid Sci. Technol. 108 (2006), 707–708.
153. [153] Griffiths, W.J., Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids. Mass Spectrom. Rev. 22 (2003), 81–152.
154. [154] Griffiths, W.J., Karua, K., Hornshaw, M., Woffendin, G., Wanga, Y., Metabolomics and metabolite profiling: past heroes and future developments. Eur. J. Mass Spectrom. 13 (2007), 45–50.
155. [155] Griffiths, W.J., Sjovall, J., Bile acids: analysis in biological fluids and tissues. J. Lipid Res. 51 (2010), 23–41.
156. [156] Griffiths, W.J., Wang, Y.Q., Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem. Soc. Rev. 38 (2009), 1882–1896.
157. [157] Griffiths, W.J., Wang, Y.Q., The importance of steroidomics in the study of neurodegenerative disease and ageing. Comb. Chem. High Throughput Screen. 12 (2009), 212–228.
158. [158] Ogundare, M., Theofilopoulos, S., Lockhart, A., Hall, L.J., Arenas, E., Sjovall, J., Brenton, A.G., Wang, Y., Griffiths, W.J., Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?. J. Biol. Chem. 285 (2010), 4666–4679.
159. [159] Badoud, F., Boccard, J., Schweizer, C., Pralong, F., Saugy, M., Baume, N., Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. J. Steroid Biochem. Mol. Biol. 138 (2013), 222–235.
160. [160] Boccard, J., Badoud, F., Grata, E., Ouertani, S., Hanafi, M., Mazerolles, G., Lanteri, P., Veuthey, J.L., Saugy, M., Rudaz, S., A steroidomic approach for biomarkers discovery in doping control. Forensic Sci. Int. 213 (2011), 85–94.
161. [161] Boccard, J., Badoud, F., Jan, N., Nicoli, R., Schweizer, C., Pralong, F., Veuthey, J.L., Baume, N., Rudaz, S., Saugy, M., Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing. Bioanalysis 6 (2014), 2523–2536.
162. [162] Jeanneret, F., Boccard, J., Badoud, F., Sorg, O., Tonoli, D., Pelclova, D., Vlckova, S., Rutledge, D.N., Samer, C.F., Hochstrasser, D., Saurat, J.H., Rudaz, S., Human urinary biomarkers of dioxin exposure: analysis by metabolomics and biologically driven data dimensionality reduction. Toxicol. Lett. 230 (2014), 234–243.
163. [163] Kumar, B.S., Chung, B.C., Kwon, O.S., Jung, B.H., Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J. Appl. Toxicol. 32 (2012), 505–520.
164. [164] Kumar, B.S., Lee, Y.J., Yi, H.J., Chung, B.C., Jung, B.H., Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Anal. Chim. Acta 661 (2010), 47–59.
165. [165] Knight, A., Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. Rev. Recent Clin. Trials 3 (2008), 89–96.
166. [166] O'Connor, M.D., The 3R principle: advancing clinical application of human pluripotent stem cells. Stem Cell Res. Ther. 4:21 (2013), 1–7.
167. [167] Scheltema, R.A., Decuypere, S., Dujardin, J.C., Watson, D.G., Jansen, R.C., Breitling, R., Simple data-reduction method for high-resolution LC–MS data in metabolomics. Bioanalysis 1 (2009), 1551–1557.
168. [168] Takahashi, H., Morimoto, T., Ogasawara, N., Kanaya, S., AMDORAP: non-targeted metabolic profiling based on high-resolution LC–MS. BMC Bioinformatics 12:259 (2011), 1–8.
169. [169] Spaggiari, D., Fekete, S., Eugster, P.J., Veuthey, J.L., Geiser, L., Rudaz, S., Guillarme, D., Contribution of various types of liquid chromatography–mass spectrometry instruments to band broadening in fast analysis. J. Chromatogr. A 1310 (2013), 45–55.
170. [170] Dunn, W.B., Erban, A., Weber, R.J.M., Creek, D.J., Brown, M., Breitling, R., Hankemeier, T., Goodacre, R., Neumann, S., Kopka, J., Viant, M.R., Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9 (2013), S44–S66.
171. [171] Stachulski, A.V., Meng, X.L., Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides. Nat. Prod. Rep. 30 (2013), 806–848.
172. [172] Stachulski, A.V., Harding, J.R., Lindon, J.C., Maggs, J.L., Park, B.K., Wilson, I.D., Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis. J. Med. Chem. 49 (2006), 6931–6945.
173. [173] Waller, C.C., McLeod, M.D., A simple method for the small scale synthesis and solid-phase extraction purification of steroid sulfates. Steroids 92 (2014), 74–80.
174. [174] Al-Horani, R.A., Desai, U.R., Chemical sulfation of small molecules-advances and challenges. Tetrahedron 66 (2010), 2907–2918.
175. [175] Clements, M., Li, L.A., Strategy of using microsome-based metabolite production to facilitate the identification of endogenous metabolites by liquid chromatography mass spectrometry. Anal. Chim. Acta 685 (2011), 36–44.
176. [176] Williams, T.M., Kind, A.J., Houghton, E., Hill, D.W., Electrospray collision-induced dissociation of testosterone and testosterone hydroxy analogs. J. Mass Spectrom. 34 (1999), 206–216.
177. [177] Wooding, K.M., Barkley, R.M., Hankin, J.A., Johnson, C.A., Bradford, A.P., Santoro, N., Murphy, R.C., Mechanism of formation of the major estradiol product ions following collisional activation of the molecular anion in a tandem quadrupole mass spectrometer. J. Am. Soc. Mass Spectr. 24 (2013), 1451–1455.
178. [178] Yan, Y., Rempel, D.L., Holy, T.E., Gross, M.L., Mass spectrometry combinations for structural characterization of sulfated-steroid metabolites. J. Am. Soc. Mass Spectrom. 25 (2014), 869–879.
179. [179] Hill, D.W., Kertesz, T.M., Fontaine, D., Friedman, R., Grant, D.F., Mass spectral metabonomics beyond elemental formula: chemical database querying by matching experimental with computational fragmentation spectra. Anal. Chem. 80 (2008), 5574–5582.
180. [180] Wolf, S., Schmidt, S., Muller-Hannemann, M., Neumann, S., In silico fragmentation for computer assisted identification of metabolite mass spectra. BMC Bioinformatics 11:148 (2010), 1–12.
181. [181] Menikarachchi, L.C., Cawley, S., Hill, D.W., Hall, L.M., Hall, L., Lai, S., Wilder, J., Grant, D.F., MolFind: a software package enabling HPLC/MS-based identification of unknown chemical structures. Anal. Chem. 84 (2012), 9388–9394.
182. [182] Kertesz, T.M., Hill, D.W., Albaugh, D.R., Hall, L.H., Hall, L.M., Grant, D.F., Database searching for structural identification of metabolites in complex biofluids for mass spectrometry-based metabonomics. Bioanalysis 1 (2009), 1627–1643.
183. [183] Kertesz, T.M., Hall, L.H., Hill, D.W., Grant, D.F., CE50: quantifying collision induced dissociation energy for small molecule characterization and identification. J. Am. Soc. Mass Spectr. 20 (2009), 1759–1767.